By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases ...

FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced that William Hinshaw, Chief Executive ...

Gene Mack will give a virtual corporate presentation. Interested investors are encouraged to contact their Oppenheimer representative to schedule one-on-one meetings with Gain management. If you are ...

Amgen (NASDAQ: AMGN ) will present at Citi's 2025 Virtual Oncology Leadership Summit at 3:00 p.m. ET on Wednesday, Feb. 19, 2025. Jean-Charles Soria, senior vice president of oncology within global ...

Sleep-apnoea-tackling Resmed is dreaming big but the question is: what can upset the Aussie biotech's growth story?

Piper Sandler, a well-known investment firm, increased its price target on shares of Amgen (NASDAQ:AMGN) to $329.00, up from the previous target of $310.00. The firm has maintained its Overweight ...

Purple Biotech Ltd., a clinical-stage bio-pharmaceutical company, is set to present its ... Conference in a Fireside Chat presentation (virtual) and one-on-one meetings. The conference is being ...

AQILION AB (publ) today announces that the company has divested its entire holding in Oncorena Holding AB. The decision is in line with Aqilion's strategy to focus the business to the internal ...

Welcome to Career Coach, a column for job seekers and employees navigating the ins and outs of finding, landing and succeeding in jobs in the biotech industry. Each month, Carina Clingman, founder of ...